Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
7.54% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
TGTX · Jun 30, 2024
TG THERAPEUTICS, INC.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001437749-24-025853General Corporate
Evidence method
Yoy · gp.fundamentals.revenue
357.05% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
110.59% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.gross_margin
88.70% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
12.00% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
23.90% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
12.93% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History17 statesSelf-history eligible
Jun 30, 20220/7 normalizedLevel 3Sep 30, 20220/7 normalizedLevel 3Dec 31, 20220/7 normalizedLevel 3Mar 31, 20230/7 normalizedLevel 3Jun 30, 20235/7 normalizedLevel 3Sep 30, 20235/8 normalizedLevel 3Dec 31, 20235/9 normalizedLevel 3Mar 31, 20244/7 normalizedLevel 3Jun 30, 20245/7 normalizedLevel 3Sep 30, 20245/7 normalizedLevel 3Dec 31, 20246/8 normalizedLevel 3Mar 31, 20257/8 normalizedLevel 3Jun 30, 20257/8 normalizedLevel 3Sep 30, 20258/8 normalizedLevel 3Dec 31, 20258/8 normalizedLevel 3Mar 31, 20268/8 normalizedLevel 3Jun 30, 20268/8 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- -12.93%
- Current
- 7.54%
- Delta
- 20.47%
- Previous
- 713.46%
- Current
- 357.05%
- Delta
- -356.41%
- Previous
- 122.44%
- Current
- 110.59%
- Delta
- -11.86%
- Previous
- 91.43%
- Current
- 88.70%
- Delta
- -2.73%
- Previous
- -14.60%
- Current
- 12.00%
- Delta
- 26.60%
- Previous
- 51.55%
- Current
- 23.90%
- Delta
- -27.66%
- Previous
- 14.71%
- Current
- 12.93%
- Delta
- -1.78%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · TGTX Fundamental State →Analogous To · TGTX state analogue 4 →Has State · TG THERAPEUTICS, INC. →Transitioned To · TGTX Fundamental State →Transitioned To · TGTX CASH_GENERATION_INCREASED →Transitioned To · TGTX GROWTH_DECREASED →Transitioned To · TGTX INVENTORY_PRESSURE_DECREASED →Transitioned To · TGTX MARGIN_DECREASED →Transitioned To · TGTX PROFITABILITY_INCREASED →Transitioned To · TGTX R_AND_D_INTENSITY_DECREASED →Transitioned To · TGTX SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.